These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3473621)

  • 1. Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P; Manthorpe R; Andersen V
    Scand J Rheumatol Suppl; 1986; 61():135-8. PubMed ID: 3473621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P; Manthorpe R; Andersen V
    Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P
    Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number.
    Izumi Y; Ida H; Huang M; Iwanaga N; Tanaka F; Aratake K; Arima K; Tamai M; Kamachi M; Nakamura H; Origuchi T; Kawakami A; Anderson P; Eguchi K
    J Lab Clin Med; 2006 May; 147(5):242-9. PubMed ID: 16697772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell-mediated immunity in patients with Sjogren's syndrome].
    Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
    Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell functions are related to the cell membrane composition of essential fatty acids: differences in healthy persons and patients with primary Sjögren's syndrome.
    Oxholm P; Pedersen BK; Horrobin DF
    Clin Exp Rheumatol; 1992; 10(3):229-34. PubMed ID: 1582067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
    Katano K; Kawano M; Koni I; Sugai S; Muro Y
    J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell activity in peripheral blood of highly trained and untrained persons.
    Pedersen BK; Tvede N; Christensen LD; Klarlund K; Kragbak S; Halkjr-Kristensen J
    Int J Sports Med; 1989 Apr; 10(2):129-31. PubMed ID: 2722326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressed natural killer cell activity in acute myocardial infarction.
    Klarlund K; Pedersen BK; Theander TG; Andersen V
    Clin Exp Immunol; 1987 Oct; 70(1):209-16. PubMed ID: 3500813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
    Miyasaka N; Murota N; Yamaoka K; Sato K; Yamada T; Nishido T; Okuda M
    Clin Exp Immunol; 1986 Sep; 65(3):497-505. PubMed ID: 3490935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killing activity in Sjögren's syndrome. An analysis of defective mechanisms.
    Miyasaka N; Seaman W; Bakshi A; Sauvezie B; Strand V; Pope R; Talal N
    Arthritis Rheum; 1983 Aug; 26(8):954-60. PubMed ID: 6882489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
    Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
    Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells in connective tissue disorders.
    Sibbitt WL; Bankhurst AD
    Clin Rheum Dis; 1985 Dec; 11(3):507-21. PubMed ID: 3907953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
    Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
    Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired natural killing activity in patients with rheumatoid arthritis. Clinical characteristics and a study of defective mechanisms.
    Fantini F; Valenti F; Mercuriali F; Marin F; Panajotopoulos N
    Boll Ist Sieroter Milan; 1986; 65(1):40-6. PubMed ID: 3487336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo CD(+) T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation.
    Koarada S; Haruta Y; Mitamura M; Morito F; Tada Y; Ohta A; Nagasawa K
    Rheumatology (Oxford); 2006 Apr; 45(4):392-9. PubMed ID: 16287915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial immunoglobulin deposits and Langerhans cells in patients with primary Sjögren's syndrome.
    Oxholm P
    Dan Med Bull; 1989 Sep; 36(4):358-68. PubMed ID: 2680309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.
    Hansen A; Gosemann M; Pruss A; Reiter K; Ruzickova S; Lipsky PE; Dörner T
    Arthritis Rheum; 2004 Jun; 50(6):1897-908. PubMed ID: 15188366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell function in trisomy-21 (Down's syndrome).
    Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
    Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.